Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
M. De la Calle, C. Vidaurrázaga, N. Martinez, M. González-Beato, E. Antolín & J. L. Bartha. (2017) Successful treatment of a severe early onset case of pemphigoid gestationis with intravenous immunoglobulin in a twin pregnancy conceived with in vitro fertilisation in a primigravida. Journal of Obstetrics and Gynaecology 37:2, pages 246-247.
Read now
Read now
Ayse Oktem, Bengu Nisa Akay, Ayse Boyvat, Nihal Kundakci, Cengizhan Erdem, Seher Bostancı, Hatice Sanli & Pelin Kocyigit. (2017) Long-term results of rituximab–intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy. Journal of Dermatological Treatment 28:1, pages 50-54.
Read now
Read now
Mareike Witte, Hiroshi Koga, Takashi Hashimoto, Ralf J. Ludwig & Katja Bieber. (2016) Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita. Expert Opinion on Therapeutic Targets 20:8, pages 985-998.
Read now
Read now
Articles from other publishers (51)
Nika Kianfar, Shayan Dasdar, Maryam Daneshpazhooh, Zeinab Aryanian & Azadeh Goodarzi. (2023) A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy. Experimental Dermatology 32:7, pages 934-944.
Crossref
Crossref
Samuel Ruiz, Brittany PueblaNoel HernandezViviana RubioElizabeth YoungHaaris Mir. (2023) Pemphigus Vulgaris. Annals of Plastic Surgery 91:1, pages 62-63.
Crossref
Crossref
Anahita Kate, Swapna S Shanbhag, Pragnya R Donthineni, Guillermo Amescua, Victor L Perez Quinones & Sayan Basu. (2023) Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease. Indian Journal of Ophthalmology 71:4, pages 1176-1189.
Crossref
Crossref
Denise Miyamoto, Juliana Olivieri Gordilho, Claudia Giuli Santi & Adriana Maria Porro. (2022) Epidermolysis bullosa acquisita. Anais Brasileiros de Dermatologia 97:4, pages 409-423.
Crossref
Crossref
Jack Jeskey, Lauren Fill, Madiha Huq, Sandeep Sarkaria, Remie Saab & Robert Hostoffer. 2022. Absolute Allergy and Immunology Board Review. Absolute Allergy and Immunology Board Review
185
191
.
John M. Wright, Paras Patel & Yi-Shing Lisa Cheng. 2022. Peterson’s Principles of Oral and Maxillofacial Surgery. Peterson’s Principles of Oral and Maxillofacial Surgery
1137
1168
.
Reece D Burns, Develyn Vetos & Richard Muraga. (2021) A Case of Severe Bullous Dermatitis With Mixed Bullous Pemphigoid and Pemphigus Vulgaris Cutaneous Manifestations. Cureus.
Crossref
Crossref
Anastasiya Muntyanu, Elena Netchiporouk, William Gerstein, Robert Gniadecki & Ivan V. Litvinov. (2020) Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management. Journal of Cutaneous Medicine and Surgery 25:1, pages 59-76.
Crossref
Crossref
F. Boria, R. Maseda, F. Albízuri & M. de la Calle. (2021) Intravenous Immunoglobulin Therapy for Gestational Pemphigoid Refractory to Conventional Treatment. Actas Dermo-Sifiliográficas (English Edition) 112:1, pages 83-85.
Crossref
Crossref
F. Boria, R. Maseda, F. Albízuri & M. de la Calle. (2021) Tratamiento con inmunoglobulinas intravenosas del penfigoide gestacional refractario al tratamiento convencional. Actas Dermo-Sifiliográficas 112:1, pages 83-85.
Crossref
Crossref
Mathias Sulk, Tobias Goerge & Thomas A. Luger. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
397
404.e5
.
V. Hébert, T. Vermeulin, L. Tanguy, B. Tedbirt, C. Mignard, J. Bénichou & P. Joly. (2020) Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial. British Journal of Dermatology 183:1, pages 121-127.
Crossref
Crossref
Sergei A. Grando, Michael Rigas & Alex Chernyavsky. (2020) Rationale for including intravenous immunoglobulin in the multidrug protocol of curative treatment of pemphigus vulgaris and development of an assay predicting disease relapse. International Immunopharmacology 82, pages 106385.
Crossref
Crossref
Jennifer B. Mancuso & Pranita V. Rambhatla. 2020. Practical Guide to Dermatology. Practical Guide to Dermatology
1
21
.
K. Kridin, E.H. Kowalski, D. Kneiber, R. Laufer‐Britva & K.T. Amber. (2019) From bench to bedside: evolving therapeutic targets in autoimmune blistering disease. Journal of the European Academy of Dermatology and Venereology 33:12, pages 2239-2252.
Crossref
Crossref
Enno Schmidt, Michael Kasperkiewicz & Pascal Joly. (2019) Pemphigus. The Lancet 394:10201, pages 882-894.
Crossref
Crossref
Sergei A. Grando. (2018) Retrospective analysis of a single‐center clinical experience toward development of curative treatment of 123 pemphigus patients with a long‐term follow‐up: efficacy and safety of the multidrug protocol combining intravenous immunoglobulin with the cytotoxic immunosuppressor and mitochondrion‐protecting drugs. International Journal of Dermatology 58:1, pages 114-125.
Crossref
Crossref
Masato Takeuchi, Shuichi Ito, Masaki Nakamura & Koji Kawakami. (2018) Changes in Hemoglobin Concentrations Post-immunoglobulin Therapy in Patients with Kawasaki Disease: A Population-Based Study Using a Claims Database in Japan. Pediatric Drugs 20:6, pages 585-591.
Crossref
Crossref
M.S. Min, E. Damstetter & A.Y.Y. Chen. (2018) Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. International Journal of Women's Dermatology 4:3, pages 159-165.
Crossref
Crossref
Havva Hilal Ayvaz, Müzeyyen Gönül & Seda Atay. 2018. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases.
Danka Svecova. 2018. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases.
Filipa Tavares Almeida, Rita Sarabando, Joana Pardal & Celeste Brito. (2018) Pemphigoid gestationis successfully treated with intravenous immunoglobulin. BMJ Case Reports, pages bcr-2018-224346.
Crossref
Crossref
Anes Yang, Ronald Chin & Dedee F. Murrell. (2018) Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy. Otolaryngology Case Reports 6, pages 1-3.
Crossref
Crossref
Ines Lakoš Jukić, Sandra Jerković Gulin & Branka Marinović. (2018) Blistering diseases in the mature patient. Clinics in Dermatology 36:2, pages 231-238.
Crossref
Crossref
Mayumi Kamaguchi, Hiroaki Iwata, Yuiko Mori, Ellen Toyonaga, Hideyuki Ujiie, Yoshimasa Kitagawa & Hiroshi Shimizu. (2017) Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion. Frontiers in Immunology 8.
Crossref
Crossref
K.E. HarmanD. BrownL.S. ExtonR.W. GrovesP.J. HamptonM.F. Mohd MustapaJ.F. SetterfieldP.D. YesudianP.M. McHenry, K. Gibbon, D.A. Buckley, T.A. Leslie, E.C. Mallon, S. Wakelin, S. Ungureanu, R.Y.P. Hunasehally, M. Cork, G.A. Johnston, J. Natkunarajah, F.S. Worsnop, N. Chiang, C.E. Duarte Williamson, J. Donnelly, C. Saunders & A.G. Brain. (2017) British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017. British Journal of Dermatology 177:5, pages 1170-1201.
Crossref
Crossref
J. Ruiz-Rivero, I. Hernández-Aragüés, A. Pulido-Pérez & R. Suárez-Fernández. (2017) Linear IgA Bullous Dermatosis Presenting as Toxic Epidermal Necrolysis. Actas Dermo-Sifiliográficas (English Edition) 108:9, pages 880-882.
Crossref
Crossref
J. Ruiz-Rivero, I. Hernández-Aragüés, A. Pulido-Pérez & R. Suárez-Fernández. (2017) Dermatosis ampollosa IgA lineal con presentación clínica de necrólisis epidérmica tóxica. Actas Dermo-Sifiliográficas 108:9, pages 880-882.
Crossref
Crossref
Chau Yee Ng, Sybren de Hoog, Hua-En Li, Yung-Yi Lee, Chun-Bing Chen & Pei-Lun Sun. (2016) Cutaneous Exophiala oligosperma Infection in a Patient with Bullous Pemphigoid with a Review of the Literature. Mycopathologia 182:5-6, pages 539-547.
Crossref
Crossref
Margit Juhász, Megan Rogge, Mary Chen, Annette Czernik, Soo Jung Kim & Lauren Geller. (2017) Case of Pediatric Bullous Systemic Lupus Erythematosus Treated with Intravenous Immunoglobulin. Pediatric Dermatology 34:1, pages e54-e56.
Crossref
Crossref
. 2017. Diagnostic Pathology: Nonneoplastic Dermatopathology. Diagnostic Pathology: Nonneoplastic Dermatopathology
96
97
.
Jie Zheng, Meng Pan, S. Gianfaldoni, A. M. D’Erme, T. Lotti, Xingqi Zhang, Peng Zhang, Jin Yuan, Qianjin Lu, Ken Hashimoto & Fiona Lewis. 2017. Practical Immunodermatology. Practical Immunodermatology
297
340
.
Minhee Kim, Luca Borradori & Dédée F. Murrell. (2016) Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management. Drugs & Aging 33:10, pages 711-723.
Crossref
Crossref
A. Razzaque Ahmed, Shawn Shetty, Srini Kaveri & Zachary S. Spigelman. (2016) Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up. Journal of the American Academy of Dermatology 74:4, pages 700-708.e3.
Crossref
Crossref
Sarah Madeline Brown & Philip Jeremy Hampton. (2016) Haemolytic Anaemia Following High Dose Intravenous Immunoglobulin Treatment for Epidermolysis Bullosa Acquisita. Pharmacology & Pharmacy 07:01, pages 25-28.
Crossref
Crossref
Isaak Effendy. 2016. Anogenitale Hautkrankheiten. Anogenitale Hautkrankheiten
99
196
.
Elizabeth M. Moore & Victoria P. Werth. 2016. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases
149
162
.
Kara Heelan, Scott Walsh & Neil H. Shear. 2016. Autoimmune Bullous Diseases. Autoimmune Bullous Diseases
19
40
.
Naveed Sami. (2015) Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up. JAAD Case Reports 1:5, pages 321-323.
Crossref
Crossref
R. Eming. (2015) PemphigusPemphigus. Der Hautarzt 66:8, pages 574-582.
Crossref
Crossref
A. Razzaque Ahmed & Shawn Shetty. (2015) The Emerging Role of Rituximab in Autoimmune Blistering Diseases. American Journal of Clinical Dermatology 16:3, pages 167-177.
Crossref
Crossref
Caroline P. Allen & Vanessa A. Venning. 2015. Blistering Diseases. Blistering Diseases
561
563
.
Mae N. Ramirez-Quizon, Luca Borradori, Russell P. HallIIIIII & Dédée F. Murrell. 2015. Blistering Diseases. Blistering Diseases
543
550
.
Raman Mehrzad, Shawn Shetty & A. Razzaque Ahmed. 2015. Genomics, Personalized Medicine and Oral Disease. Genomics, Personalized Medicine and Oral Disease
219
251
.
Brian Markoff & Jacob Levitt. (2014) Vesiculobullous Skin Disease. Hospital Medicine Clinics 3:4, pages 582-596.
Crossref
Crossref
Asli Hapa, Ahmet Gurpinar, Tulin Akan & Ozay Gokoz. (2014) A resistant case of pemphigus gestationis successfully treated with intravenous immunoglobulin plus cyclosporine. International Journal of Dermatology 53:4, pages e269-e271.
Crossref
Crossref
Bum Joon KoKyu Uang Whang. (2014) Intravenous Immunoglobulin Therapy for Persistent Pemphigoid Gestationis with Steroid Induced Iatrogenic Cushing's Syndrome. Annals of Dermatology 26:5, pages 661.
Crossref
Crossref
F. Schulze, M. Kasperkiewicz, D. Zillikens & E. Schmidt. (2013) Bullöses PemphigoidBullous pemphigoid. Der Hautarzt 64:12, pages 931-945.
Crossref
Crossref
Marzieh Niknami, Min‐Xia Wang, Toan Nguyen & John D. Pollard. (2013) Beneficial effect of a multimerized immunoglobulin Fc in an animal model of inflammatory neuropathy (experimental autoimmune neuritis). Journal of the Peripheral Nervous System 18:2, pages 141-152.
Crossref
Crossref
. (2013) Current World Literature. Current Opinion in Rheumatology 25:2, pages 275-283.
Crossref
Crossref
Leslie P. Cousens, Ryan Tassone, Bruce D. Mazer, Vasanthi Ramachandiran, David W. Scott & Anne S. De Groot. (2013) Tregitope update: Mechanism of action parallels IVIg. Autoimmunity Reviews 12:3, pages 436-443.
Crossref
Crossref